GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Capital Expenditure

Control Bionics (ASX:CBL) Capital Expenditure : A$-0.09 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Control Bionics's cash flow for capital expenditures for the six months ended in Dec. 2024 was A$-0.21 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.09 Mil.

Control Bionics Capital Expenditure Historical Data

The historical data trend for Control Bionics's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Capital Expenditure Chart

Control Bionics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Capital Expenditure
-0.05 -0.15 -0.46 -0.47

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only -0.33 -0.12 -0.59 0.12 -0.21

Control Bionics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Capital Expenditure
Comparable Companies
ASX:HMD ASX:AT1 ASX:IRX ASX:ADRDA ASX:UCM ASX:UBI ASX:OSL ASX:CDX ASX:LDX ASX:NTI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Website
https://www.controlbionics.com
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.